Biological drugs, or biologics, are innovative therapies for people with debilitating and life-threatening diseases; but these drugs are expensive. In this Q&A, AIR’s Thiyagu Rajakannan, senior researcher and lead for Drug Coverage and Payment Practice in the Health Division at AIR, explains how lower-cost versions of these drugs and promising ...
AIR is conducting a rigorous evaluation of Montessori preschool programs in public schools to understand differences in student outcomes and program costs compared to other preschool models.
The Indiana Choice Scholarship Program, launched in 2011, offers a rich opportunity to study how a large-scale tuition-voucher program works and to analyze the results it has produced in its first few years. This article describes the results of a four-year study of the Indiana program.
This research brief shares findings related to participants’ awareness of xenotransplantation as a potential future kidney transplant option in light of recent advancements. We also discuss what the participants perceived as the benefits and risks of xenotransplantation as well as their recommendations for when and how patients, families, and clinicians ...
Maureen Maurer is a managing director in the Health program at AIR. With more than 20 years of experience, her portfolio of work involves engaging patients, families, and community in health research, health care delivery, and health policy; communicating about medical evidence to lay and professional audiences; and efforts to ...
To address the complex needs of at-risk and homeless families, the Strengthening At Risk and Homeless Young Mothers and Children initiative was created. The Initiative sought to improve the housing, health, and development of homeless and at-risk mothers and children by supporting locally-based partnerships that included housing/homelessness and child development ...